Financhill
Back

Aligos Therapeutics Stock Predictions

Aligos Therapeutics Stock Forecast

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 37.1% based on the past 4 years of stock performance.
  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Aligos Therapeutics Stock Undervalued?
    The current Aligos Therapeutics [ALGS] share price is $18.20. The Score for ALGS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 37.1% based on the past 4 years of stock performance.

Aligos Therapeutics Stock Rating

Buy
55
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics overpriced?

  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Aligos Therapeutics Stock Price History

Is ALGS stock going to rise?

  • The current trend is moderately bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com

52-Week Data

52-Week High:
30.00
52-Week Low:
6.76

Prediction Charts

Market Cap:
65.3M
Price in USD:
18.20
Volume:
471.77K
Beta:
2.13

Technical Analysis

SMA50:
10.58
SMA100:
11.76
SMA200:
15.33
52-Wk Change:
1.42%

Stock Predictions

  • Is Aligos Therapeutics stock public?
    Yes, Aligos Therapeutics is a publicly traded company.
  • What is the Aligos Therapeutics stock quote today?
    The Aligos Therapeutics stock price is 18.20 USD today.
  • How to buy Aligos Therapeutics stock online?
    You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 9.81 9.55 10.30 9.33
Nov-4 9.58 9.42 9.89 9.35
Nov-5 9.51 9.83 9.88 9.32
Nov-6 10.00 9.35 10.00 9.20
Nov-7 9.08 9.92 10.45 9.02
Nov-8 9.87 10.19 10.41 9.68
Nov-11 10.32 14.00 17.70 10.32
Nov-12 15.46 17.90 18.00 14.09
Nov-13 18.80 19.45 21.89 18.20
Nov-14 19.43 19.46 20.44 15.66
Nov-15 19.91 19.17 20.59 17.26
Nov-18 19.45 20.12 20.15 17.85
Nov-19 19.79 18.50 24.84 14.65
Nov-20 18.51 18.20 19.85 17.88

Aligos Therapeutics Earnings

Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics Forecast Revenue Growth

Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.